Six-year distribution pattern of hepatitis C virus in Turkey: A multicentre study

Biotechnology and Biotechnological Equipment

Volumn 30, Issue 2, 2015, Pages 335-340

  Altindis, Mustafa ^a   Dal, Tuba ^b   Akyar, Isin ^c   Karatuna, Onur ^c   Gokahmetoglu, Selma ^d   Ulger, Seda Tezcan ^e   Kulah, Canan ^f   Uzun, Berrin ^g   Şener, Aslı Gamze ^g   Ozdemirh, Mehmet ^h   Aydogan, Sibel ⁱ   Kuskucu, Mert Ahmet ^j   Midilli, Kenan ^j   Otlu, Baris ^k   Celen, Mustafa Kemal ^l   Burukm, Kurtulus ^m   Guducuoglu, Huseyin ⁿ  

^a SAKARYA UNIVERSITY   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^c ACIBADEM UNIVERSITY   (Turkey)

^d ERCIYES UNIVERSITY   (Turkey)

^e MERSIN UNIVERSITY   (Turkey)

^f ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^g IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^h NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

ⁱ ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^j ISTANBUL UNIVERSITY   (Turkey)

^k INONU UNIVERSITY   (Turkey)

^l DICLE UNIVERSITY   (Turkey)

^m KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

ⁿ YUZUNCU YIL UNIVERSITY   (Turkey)

more..

Author keywords

Genotypes; Hepatitis C; Turkey

Indexed keywords

BIOTECHNOLOGY; GENETIC ENGINEERING;

DISTRIBUTION PATTERNS; GENOTYPES; HEPATITIS C; HEPATITIS C VIRUS; MULTI-CENTRE STUDY; THERAPEUTIC STRATEGY; TURKEY; WHITNEY;

VIRUSES;

EID: 84959457513     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.1080/13102818.2015.1093430     Document Type: Article

References (28)

1. Rigat K, Wang Y, Hudyma TW, et al. Ligand-inducedchanges in hepatitis C virus NS5B polymerase structure. Antiviral Res. 2010; 88(2): 197-206.
2. Marascio N, Matera G, Quirino A, et al. Eleven-year distribution pattern of hepatitis C virus in Southern Italy. JPathog. 2012; 2012: 631095.
3. Lauer GM, Walker BD. Hepatitis C virus infection. New EnglJ Med. 2001; 345: 41-52.
4. Dayan S, Tekin A, Tekin R, et al. HBsAg, anti-HCV, anti-HIV1/2 and syphilis seroprevalence in healthy volunteerblood donors in southeastern Anatolia. J Infect Dev Ctries. 2013; 7(9): 665-669.
5. Bostan N, Mahmood T. An overview about hepatitis C: adevastating virus. Crit Rev Microbiol. 2010; 36(2): 91-133.
6. Reker C, Islam KM. Risk factors associated with high prevalence rates of hepatitis C infection in Egypt. Int J InfectDis. 2014; 25: 104-106.
7. Alter, MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007; 13(17): 2436-2441.
8. Centers for Disease Control and Prevention. Hepatitis Cinformation for health professionals [Internet]. Atlanta(GA): CDC; 2015 [cited 2015 May 31]. Available from: http: //www. cdc. gov/hepatitis/hcv/index. htm
9. Dubuisson J. Hepatitis C virus proteins. World J Gastroenterol. 2007; 13(7): 2406-2415.
10. Jubin R. Hepatitis C IRES: translating translation into a therapeutic target. Curr Opin Mol Ther. 2001; 3(3): 278-287.
11. Kalayci R, Altindis M, Gulamber G, et al. Genotype distribution of chronic hepatitis B and hepatitis C patients andinvestigation of the resistance patterns in hepatitis Bcases. Mikrobiyol Bull. 2010; 44(2): 237-243.
12. Altuglu I, Soyler I, Ozacar T, et al. Distribution of hepatitis Cvirus genotypes in patients with chronic hepatitis C infection in Western Turkey. Int JInfect Dis. 2008: 12(3): 239-244.
13. Simmonds P, Bukh J, Combet C, et al. Consensus proposals for a unified system of nomenclature of hepatitis Cvirus genotypes. Hepatology. 2005; 42(4): 962-973.
14. Antaki N, Craxi A, Kamal S, et al. The neglected hepatitis Cvirus genotypes 4, 5 and 6: an international consensusreport. Liver Int. 2010; 30: 342-355.
15. Saglik I, Mutlu D, Ongut G, et al. Distribution of hepatitis Cvirus genotypes among patients with chronic hepatitis Cinfection in Akdeniz University Hospital, Antalya, Turkey: afive-year evaluation. Mikrobiyol Bull. 2014; 48(3): 429-437. Turkish.
16. Tezcan S, Ulger M, Aslan G, et al. Determination of hepatitis C virus genotype distribution in Mersin province, Turkey. Mikrobiyol Bull. 2013; 47(2): 332-338.
17. AktaŞ E, Ogedey ED, Ke ulah C, et al. Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey. Mikrobiyol Bull. 2010; 44(4): 647-650.
18. Sunbul M. Hepatitis B virus genotypes: global distributionand clinical importance. World J Gastroenterol. 2014; 20(18): 5427-5434.
19. Pizzillo P, Almasio PL, Ferraro D, et al. HCV genotypes inSicily: is there any evidence of a shift? J Med Virol. 2009; 81(6): 1040-1046.
20. Curcio F, Villano G, Masucci S, et al. Epidemiological survey of hepatitis C virus infection in a cohort of patientsfrom a ser. T in naples, Italy. J Addict Med. 2011; 5(1)43-49.
21. Sereno S, Perinelli P, Laghi V. Changes in the prevalence ofhepatitis C virus genotype among Italian injection drugusers-Relation to period of injection started. J Clin Virol. 2009; 45(4): 354-357.
22. Antaki N, Haddad M, Kebbewar K, et al. Syrian workinggroup for the study of viral hepatitis. The unexpected discovery of a focus of hepatitis C virus genotype 5 in aSyrian province. Epidemiol Infect. 2009; 137(1): 79-84.
23. Moghadam FS, Mohebbi SR, Hosseini SM, et al. Phylogenetic analysis of hepatitis C virus strains and risk factors associated with infection and viral subtypesamong Iranian patients. J Med Virol. 2014; 86(8): 1342-1349.
24. Al-Kubaisy WA, Obaid KJ, Noor NA, et al. Hepatitis C virusprevalence and genotyping among hepatocellularcarcinoma patients in Baghdad. Asian Pac J Cancer Prev. 2014; 15(18): 7725-7730.
25. Ansaldi F, Bruzzone B, Salmaso S, et al. Different seroprevalence and molecular epidemiology patterns of hepatitisC virus infection in Italy. J Med Virol. 2005: 76(3): 327-332.
26. Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C [Internet]. [cited 2015 June 30]. Available from: http: //www. hcvguidelines. org/
27. Yu ML, Chuang WL. Treatment of chronic hepatitis C inAsia: when East meets West. J Gastroenterol Hepatol. 2009; 24(3): 336-345.
28. Shepard CW, Finelli L, Alter MJ. Global epidemiology ofhepatitis C virus infection. Lancet Infect Dis. 2005; 5(9): 558-567.